This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bendeck, M. P. Search for Related Content PubMed PubMed Citation Articles by Bendeck, M. P. Related Collections Animal models of human disease Pathophysiology

(Circulation Research. 2002;90:836.)
© 2002 American Heart Association, Inc.

Editorials

Matrix Metalloproteinases

Are They Antiatherogenic but Proaneurysmal?

Michelle P. Bendeck

From the Department of Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada.

Correspondence to Dr Michelle P. Bendeck, Dept of Laboratory Medicine and Pathobiology, University of Toronto, Medical Sciences Building, 1 King’s College Cir, Room 6217A, Toronto, Ontario M5S 1A8, Canada. E-mail michelle.bendeck@ utoronto.ca

Key Words: matrix metalloproteinases • vascular remodeling • aneurysm • atherosclerosis

The matrix metalloproteinases (MMPs) are a family of enzymes (25 identified to date) that have in common the ability to degrade many molecules of the extracellular matrix. MMP activity can be inhibited by the endogenous tissue inhibitors of metalloproteinases (TIMPs 1 through 4), and the net proteolytic activity within a tissue is a function of the balance of MMPs/TIMPs.¹ Numerous studies have shown that MMPs and TIMPs are expressed during vascular remodeling in the pathological conditions of atherosclerosis, restenosis, and aneurysm formation.² Despite this burgeoning knowledge, we are still hampered by an incomplete understanding of the scope and the consequences of MMP/TIMP involvement in the pathogenesis of vascular disease.

In atherosclerosis and restenosis, MMPs are produced by the major cell types inhabiting the plaque, vascular smooth muscle cells (SMCs), and leukocytes of the monocyte/macrophage and lymphocytic lineages. MMP-1, -2, -3, -9, -12, and -13 have been detected in plaques, along with the TIMP-1, -2, and -4.² MMPs produced by SMCs clear a path for migration from media to intima by digesting the extracellular matrix, and SMC migration can be inhibited by administration of nonselective MMP inhibitors^3–5 or transfection of the genes for TIMP-1 or TIMP-2 into the injured vessel wall.^6,7 Macrophages produce abundant amounts of MMPs, which are used to invade through the endothelium and into the atherosclerotic plaque.⁸ MMPs are colocalized with macrophages in the core and shoulders of established plaques, areas that are very susceptible to the complications of erosion and rupture.⁹ MMPs are also expressed by inflammatory . . . [Full Text of this Article]

This article has been cited by other articles:

				T. Shimokawa, K. Horiuchi, N. Ozawa, K. Fumimoto, S. Manabe, T. Tobaru, and S. Takanashi Outcome of Surgical Treatment in Patients With Acute Type B Aortic Dissection Ann. Thorac. Surg., July 1, 2008; 86(1): 103 - 107. [Abstract] [Full Text] [PDF]

				T. Shimokawa, S. Takanashi, N. Ozawa, and T. Itoh Management of Intraoperative Malperfusion Syndrome Using Femoral Artery Cannulation for Repair of Acute Type A Aortic Dissection Ann. Thorac. Surg., May 1, 2008; 85(5): 1619 - 1624. [Abstract] [Full Text] [PDF]

				H. Achneck, B. Modi, C. Shaw, J. Rizzo, G. Albornoz, D. Fusco, and J. Elefteriades Ascending Thoracic Aneurysms Are Associated With Decreased Systemic Atherosclerosis Chest, September 1, 2005; 128(3): 1580 - 1586. [Abstract] [Full Text] [PDF]

				C. Guignabert, L. Taysse, J.-H. Calvet, E. Planus, S. Delamanche, S. Galiacy, and M.-P. d'Ortho Effect of doxycycline on sulfur mustard-induced respiratory lesions in guinea pigs Am J Physiol Lung Cell Mol Physiol, July 1, 2005; 289(1): L67 - L74. [Abstract] [Full Text] [PDF]

				D. S. Fusco, R. K. Shaw, M. Tranquilli, G. S. Kopf, and J. A. Elefteriades Femoral Cannulation is Safe for Type A Dissection Repair Ann. Thorac. Surg., October 1, 2004; 78(4): 1285 - 1289. [Abstract] [Full Text] [PDF]

				J. S. Ikonomidis, W. C. Gibson, J. E. Butler, D. M. McClister, S. E. Sweterlitsch, R. P. Thompson, R. Mukherjee, and F. G. Spinale Effects of Deletion of the Tissue Inhibitor of Matrix Metalloproteinases-1 Gene on the Progression of Murine Thoracic Aortic Aneurysms Circulation, September 14, 2004; 110(11_suppl_1): II-268 - II-273. [Abstract] [Full Text] [PDF]

				A. E. Cozen, H. Moriwaki, M. Kremen, M. B. DeYoung, H. L. Dichek, K. I. Slezicki, S. G. Young, M. Veniant, and D. A. Dichek Macrophage-Targeted Overexpression of Urokinase Causes Accelerated Atherosclerosis, Coronary Artery Occlusions, and Premature Death Circulation, May 4, 2004; 109(17): 2129 - 2135. [Abstract] [Full Text] [PDF]

				T. L. Medley, B. A. Kingwell, C. D. Gatzka, P. Pillay, and T. J. Cole Matrix Metalloproteinase-3 Genotype Contributes to Age-Related Aortic Stiffening Through Modulation of Gene and Protein Expression Circ. Res., June 13, 2003; 92(11): 1254 - 1261. [Abstract] [Full Text] [PDF]